Will Relieve

Product NDC
82630-003
Requested package NDC
82630-003-01
11-digit product format
826300003
Labeler code
82630
Product ID
82630-003_3f7cd406-04f4-4b92-8af6-0aa862a90871
Type
HUMAN OTC DRUG
Nonproprietary name
Lidocaine
Dosage form
AEROSOL, SPRAY
Route
TOPICAL
Labeler
Will Perform, PBC
Application
part348
Marketing category
OTC MONOGRAPH NOT FINAL
Marketing start
2022-08-01
Marketing end
0000-00-00
Substance
LIDOCAINE
Active strength
5 g/113g
Pharmacologic classes
Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC exclude flag
No
Listing certified through
2024-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage82630-00382630-003-01IInactivated by FDA2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 9 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Code, Status table
Captured / source dateCodeStatusSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05IInactivated by FDAd630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26IInactivated by FDAf5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31IInactivated by FDA2ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28IInactivated by FDAa1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21IInactivated by FDAcfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10IInactivated by FDAcdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31UExcluded because listing certification expired302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20UExcluded because listing certification expireded331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10UExcluded because listing certification expired0efc9e666f02…f202fb6c5f17…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
82630-003-012025-01-30C16284748780-12cef2736-7579-d83d-e063-dadaa90ab31fWill Relieve™ Spray

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
82630-003-01Will Relieve1 in 1 CARTONAEROSOL, SPRAY13
82630-003-01Will Relieve113 g in 1 CANAEROSOL, SPRAY1133

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
82630-003WILL RELIEVE (LIDOCAINE) AEROSOL, SPRAY [WILL PERFORM, PBC]3Legacy NDC, 2 package rows20231007_f1de4a91-7cb9-4eb4-873d-16dcd233df90.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1869797lidocaine 4 % Topical SprayPSNf1de4a91-7cb9-4eb4-873d-16dcd233df903
1869797lidocaine 40 MG/ML Topical SpraySCDf1de4a91-7cb9-4eb4-873d-16dcd233df903
1869797lidocaine 4 % Topical SpraySYf1de4a91-7cb9-4eb4-873d-16dcd233df903

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
82630-003-01826300003011 CAN in 1 CARTON (82630-003-01) > 113 g in 1 CAN1 can2022-08-010000-00-00NoNoCurrent